Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Voprosy Onkologii|January 30, 2019
[Oral vinorelbine therapy for non-small cell lung cancer: clinical and pharmacoeconomic aspects]A V Rudakova, S A ProtsenkoVoprosy Onkologii|November 18, 2015
[Gefitinib therapy in advanced non-small cell lung cancer in patients with EGFR mutations: cost-effectiveness analysis]S A Protsenko, A V RudakovaVoprosy Onkologii|February 24, 2001
[Treatment with Miltex for metastatic skin lesions in breast cancer] V M Moĭseenko, R V Orlova, N A Ermakova, et al.Voprosy Onkologii|March 15, 2011
[Frequency of expression of markers predictive of sensitivity to cytostatics in skin melanoma]A S Zhabina, S A Protsenko, A G Ievleva, et al.Voprosy Onkologii|June 20, 2015
[Systemic therapy of soft tissue sarcomas]A I Semenova, S A Protsenko, Y I Komarov, et al.Voprosy Onkologii|June 8, 2006
[High-dose Roncoleukin in patients with disseminated cutaneous melanoma: a phase 1 study]V M Moiseenko, A V Novik, R V Orlova, et al.Voprosy Onkologii|October 15, 2005
[Assessment of influence of dose variation on the effectiveness and toxicity of cytostatic therapy of disseminated breast cancer]R V Orlova, V M Moiseenko, S A Protsenko, et al.Voprosy Onkologii|November 22, 2018
[The first results of assessment of clinical efficacy of melatonin and metformin in patients with disseminated skin melanoma receiving dacarbazine as first-line systemic therapy]A V Novik, S A Protsenko, I A Baldueva, et al.Voprosy Onkologii|January 30, 2019
[Modern methods of immunotherapy for metastatic melanoma]A V Novik, I A Baldueva, S A Protsenko, et al.Voprosy Onkologii|June 20, 2015
[Efferent therapy in the treatment of solid tumors]D H Latipova, S A Protsenko, A V Novik, et al.Pageof 2